Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Italfarmaco S.p.A
Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
Study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne Muscular Dystrophy. Estudio para evaluar la eficacia y la seguridad de givinostat en pacientes ambulantes con distrofia muscular de Duchenne (DMD)
To establish the effects of givinostat versus placebo administered chronically over 18 months to slow disease progression in ambulant DMD subjects Establecer los efectos de givinostat en compara...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of ITF2357 on mucosal healing in patients with moderate-to-severe active Crohn’s Disease
To determine the ability of ITF2357 to induce complete healing of mucosal ulcerations of ileum and/or colon, assessed by endoscopy
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
An Open-Label Extension of the Dose Finding study (DSC/08/2357/36) in patients with polyarticular course Juvenile Idiopathic Arthritis (poly JIA)
The purpose of this extension study is to determine the safety of Givinostat in a long term treatment of patients who participated in DSC/08/2357/36 study with good results (clinical benefit al least ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patients
Part A: preliminary investigation of the safety, pharmacodynamics and pharmacokinetics of a new leuprolide acetate depot 3-month formulation after i.m. or s.c. administration to patients with prostate...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease
To identify one or more effective doses of ITF 2357 in the management of Crohn’s disease suitable for further evaluation in phase III studies
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
Acromegalia acromégalie
To investigate the effect of treatment on GH and IGF-1 concentrations. Étudier l’effet du traitement sur les concentrations de GH et d’IGF-1
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Italfarmaco S.p.A
Update Il y a 4 ans
A multicenter, open label, dose finding study to evaluate efficacy and safety of Givinostat administered in two different doses in patients with polyarticular course Juvenile Idiopathic Arthritis (poly JIA) not adequately responding to the standard treatment
To evaluate the efficacy of Givinostat administered in two different doses to patients with polyarticular course JIA not adequately responding to the standard treatment, to the purpose of selecting th...
Country
None
organs
None
Specialty
None
Closed trial
More information